| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 25 | 2001 | 722 | 1.400 |
Why?
|
| DNA-Binding Proteins | 23 | 2001 | 557 | 1.340 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2001 | 255 | 1.180 |
Why?
|
| Trans-Activators | 12 | 2004 | 190 | 1.140 |
Why?
|
| Transcriptional Activation | 12 | 2009 | 173 | 0.760 |
Why?
|
| Retroviridae Proteins, Oncogenic | 10 | 1994 | 27 | 0.740 |
Why?
|
| Nuclear Proteins | 9 | 2008 | 330 | 0.590 |
Why?
|
| Neoplasm Proteins | 5 | 1999 | 228 | 0.560 |
Why?
|
| DNA | 14 | 1996 | 594 | 0.510 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2011 | 293 | 0.500 |
Why?
|
| BRCA1 Protein | 9 | 2011 | 58 | 0.480 |
Why?
|
| Apoptosis | 7 | 2011 | 1541 | 0.460 |
Why?
|
| Ribonucleoproteins | 4 | 1996 | 31 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-ets | 6 | 2011 | 16 | 0.440 |
Why?
|
| Translocation, Genetic | 5 | 2004 | 40 | 0.440 |
Why?
|
| RNA-Binding Proteins | 4 | 1995 | 158 | 0.400 |
Why?
|
| Transcription, Genetic | 14 | 2004 | 599 | 0.390 |
Why?
|
| BRCA2 Protein | 3 | 2009 | 50 | 0.380 |
Why?
|
| Valproic Acid | 1 | 2011 | 21 | 0.350 |
Why?
|
| Alternative Splicing | 8 | 2009 | 92 | 0.350 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 34 | 0.350 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 44 | 0.340 |
Why?
|
| Proto-Oncogenes | 5 | 1991 | 19 | 0.340 |
Why?
|
| CREB-Binding Protein | 2 | 2009 | 13 | 0.320 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 233 | 0.300 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2001 | 15 | 0.300 |
Why?
|
| Base Sequence | 15 | 2004 | 997 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 184 | 0.280 |
Why?
|
| Dental Polishing | 1 | 2007 | 1 | 0.270 |
Why?
|
| Dental Materials | 1 | 2007 | 6 | 0.270 |
Why?
|
| Molecular Sequence Data | 15 | 1998 | 1559 | 0.260 |
Why?
|
| Cell Survival | 3 | 2011 | 934 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 1994 | 9 | 0.260 |
Why?
|
| Titanium | 1 | 2007 | 46 | 0.260 |
Why?
|
| Oncogenes | 5 | 1993 | 44 | 0.250 |
Why?
|
| RNA, Antisense | 2 | 1996 | 18 | 0.240 |
Why?
|
| Gelsolin | 1 | 2004 | 4 | 0.220 |
Why?
|
| Transfection | 10 | 2011 | 526 | 0.220 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2001 | 15 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2004 | 48 | 0.210 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 1068 | 0.210 |
Why?
|
| Amino Acid Sequence | 12 | 1998 | 1188 | 0.210 |
Why?
|
| 3T3 Cells | 9 | 1998 | 61 | 0.210 |
Why?
|
| Melanoma | 2 | 1996 | 109 | 0.210 |
Why?
|
| Cloning, Molecular | 10 | 1999 | 318 | 0.210 |
Why?
|
| ets-Domain Protein Elk-1 | 9 | 2009 | 27 | 0.210 |
Why?
|
| Animals | 34 | 2011 | 16695 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2011 | 933 | 0.190 |
Why?
|
| Immediate-Early Proteins | 2 | 1993 | 50 | 0.190 |
Why?
|
| Sequence Deletion | 2 | 1999 | 92 | 0.180 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2001 | 2 | 0.180 |
Why?
|
| Humans | 38 | 2015 | 42163 | 0.180 |
Why?
|
| Genes, p53 | 1 | 2001 | 28 | 0.180 |
Why?
|
| Breast Neoplasms | 8 | 2011 | 1679 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2007 | 429 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2004 | 40 | 0.170 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1998 | 90 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 1998 | 110 | 0.170 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2011 | 15 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1998 | 165 | 0.160 |
Why?
|
| Leukemia | 2 | 1998 | 54 | 0.160 |
Why?
|
| Proteins | 5 | 1992 | 383 | 0.160 |
Why?
|
| Acetyltransferases | 2 | 1998 | 27 | 0.150 |
Why?
|
| Mice | 17 | 2007 | 6490 | 0.150 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 5 | 2005 | 10 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 6 | 2001 | 506 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2011 | 2598 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1993 | 41 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2001 | 61 | 0.130 |
Why?
|
| COS Cells | 3 | 2011 | 67 | 0.130 |
Why?
|
| Escherichia coli | 7 | 1991 | 461 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1996 | 10 | 0.120 |
Why?
|
| Acetylation | 2 | 2011 | 108 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1994 | 139 | 0.120 |
Why?
|
| Semen | 6 | 1983 | 55 | 0.120 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 18 | 0.120 |
Why?
|
| Multiple Myeloma | 1 | 2015 | 45 | 0.120 |
Why?
|
| RNA-Binding Protein EWS | 4 | 1996 | 8 | 0.120 |
Why?
|
| Binding Sites | 7 | 1998 | 670 | 0.120 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 4 | 1996 | 13 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 1998 | 195 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1994 | 8 | 0.110 |
Why?
|
| Leukemia, Myeloid | 1 | 1994 | 9 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 427 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2011 | 383 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2001 | 136 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 160 | 0.110 |
Why?
|
| RNA Splicing | 3 | 1988 | 42 | 0.100 |
Why?
|
| Friend murine leukemia virus | 1 | 1992 | 2 | 0.100 |
Why?
|
| Avian leukosis virus | 2 | 1990 | 7 | 0.100 |
Why?
|
| Viral Structural Proteins | 1 | 1992 | 17 | 0.100 |
Why?
|
| Genes, Viral | 1 | 1992 | 64 | 0.100 |
Why?
|
| Ovarian Neoplasms | 3 | 2007 | 406 | 0.100 |
Why?
|
| Ribonucleases | 3 | 1981 | 32 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 1990 | 136 | 0.100 |
Why?
|
| Retroviridae Proteins | 2 | 1989 | 7 | 0.090 |
Why?
|
| Cell Line | 8 | 1998 | 1416 | 0.090 |
Why?
|
| Virus Integration | 1 | 1992 | 65 | 0.090 |
Why?
|
| Endoribonucleases | 2 | 1983 | 24 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 2 | 2011 | 120 | 0.090 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1992 | 115 | 0.090 |
Why?
|
| Phosphoproteins | 1 | 1993 | 201 | 0.090 |
Why?
|
| Genes, BRCA1 | 3 | 2009 | 20 | 0.090 |
Why?
|
| Caspase 7 | 1 | 2011 | 18 | 0.090 |
Why?
|
| p21-Activated Kinases | 1 | 2011 | 18 | 0.090 |
Why?
|
| Models, Biological | 2 | 2011 | 711 | 0.090 |
Why?
|
| Plasmids | 5 | 2001 | 247 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 2 | 2005 | 9 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 61 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2011 | 226 | 0.080 |
Why?
|
| Glutathione Transferase | 3 | 2001 | 90 | 0.080 |
Why?
|
| Gene Expression Regulation | 3 | 1992 | 1066 | 0.080 |
Why?
|
| SUMO-1 Protein | 1 | 2009 | 16 | 0.080 |
Why?
|
| Glycosylation | 1 | 2009 | 111 | 0.080 |
Why?
|
| X Chromosome | 1 | 1989 | 30 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1988 | 30 | 0.070 |
Why?
|
| Female | 11 | 2015 | 24018 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1988 | 36 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1420 | 0.070 |
Why?
|
| Mice, Nude | 3 | 2007 | 403 | 0.070 |
Why?
|
| Kinetochores | 1 | 2008 | 44 | 0.070 |
Why?
|
| Chromosome Segregation | 1 | 2008 | 45 | 0.070 |
Why?
|
| Dental Casting Investment | 1 | 2007 | 1 | 0.070 |
Why?
|
| Dental High-Speed Equipment | 1 | 2007 | 1 | 0.070 |
Why?
|
| Rubber | 1 | 2007 | 1 | 0.070 |
Why?
|
| Carbon Compounds, Inorganic | 1 | 2007 | 2 | 0.070 |
Why?
|
| Silicon Compounds | 1 | 2007 | 7 | 0.070 |
Why?
|
| Genes, fos | 2 | 2001 | 14 | 0.070 |
Why?
|
| Tungsten Compounds | 1 | 2007 | 16 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 1998 | 1265 | 0.070 |
Why?
|
| RNA-Binding Protein FUS | 2 | 1998 | 5 | 0.070 |
Why?
|
| Mitosis | 1 | 2008 | 112 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 158 | 0.070 |
Why?
|
| Microtubules | 1 | 2008 | 120 | 0.070 |
Why?
|
| Materials Testing | 1 | 2007 | 99 | 0.060 |
Why?
|
| Surface Properties | 1 | 2007 | 157 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 1993 | 522 | 0.060 |
Why?
|
| Seminal Vesicle Secretory Proteins | 2 | 1983 | 7 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2008 | 973 | 0.060 |
Why?
|
| Models, Genetic | 2 | 2009 | 181 | 0.060 |
Why?
|
| Glomerular Mesangium | 1 | 2005 | 6 | 0.060 |
Why?
|
| RNA | 3 | 1983 | 266 | 0.060 |
Why?
|
| Protein Binding | 3 | 2011 | 1076 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 31 | 0.060 |
Why?
|
| Serum Response Factor | 3 | 2001 | 10 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2001 | 884 | 0.060 |
Why?
|
| Mitochondria | 1 | 2009 | 516 | 0.060 |
Why?
|
| H-2 Antigens | 1 | 1985 | 5 | 0.060 |
Why?
|
| Male | 9 | 2015 | 22779 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 167 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 14 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2001 | 51 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 72 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 66 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 1998 | 534 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 295 | 0.050 |
Why?
|
| Actins | 1 | 2004 | 162 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 454 | 0.050 |
Why?
|
| Edetic Acid | 1 | 1983 | 23 | 0.050 |
Why?
|
| Rats | 5 | 2005 | 3701 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 1993 | 185 | 0.050 |
Why?
|
| Early Growth Response Protein 1 | 2 | 1993 | 10 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 1994 | 462 | 0.050 |
Why?
|
| Urea | 1 | 1983 | 44 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1983 | 56 | 0.050 |
Why?
|
| Spermine | 1 | 1983 | 65 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 1987 | 580 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 1993 | 491 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 1112 | 0.040 |
Why?
|
| Cell Division | 2 | 2007 | 314 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1998 | 22 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1991 | 45 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 254 | 0.040 |
Why?
|
| Liver | 1 | 1983 | 503 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1988 | 168 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 1979 | 30 | 0.040 |
Why?
|
| TATA Box | 1 | 1998 | 4 | 0.040 |
Why?
|
| Organ Specificity | 1 | 1999 | 141 | 0.040 |
Why?
|
| Exons | 1 | 1999 | 91 | 0.040 |
Why?
|
| Point Mutation | 2 | 2011 | 98 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1987 | 198 | 0.040 |
Why?
|
| Thymus Gland | 1 | 1999 | 74 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 1989 | 198 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 1998 | 20 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1998 | 47 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2001 | 103 | 0.040 |
Why?
|
| Genetic Markers | 1 | 1998 | 146 | 0.030 |
Why?
|
| Breast | 1 | 1999 | 139 | 0.030 |
Why?
|
| Testis | 1 | 1999 | 203 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1997 | 25 | 0.030 |
Why?
|
| Cyclins | 1 | 1997 | 37 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 649 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 95 | 0.030 |
Why?
|
| Macromolecular Substances | 3 | 1993 | 95 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 602 | 0.030 |
Why?
|
| Histones | 1 | 1998 | 194 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 508 | 0.030 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1996 | 2 | 0.030 |
Why?
|
| Avian myeloblastosis virus | 2 | 1988 | 5 | 0.030 |
Why?
|
| Cattle | 4 | 1981 | 505 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 1979 | 415 | 0.030 |
Why?
|
| Gene Expression | 1 | 1998 | 692 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1997 | 318 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1997 | 239 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1997 | 452 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1991 | 52 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 289 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1996 | 237 | 0.030 |
Why?
|
| Genes | 2 | 1985 | 56 | 0.030 |
Why?
|
| Kinetics | 1 | 1996 | 698 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1994 | 27 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1994 | 100 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 1993 | 16 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1994 | 148 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 2 | 1984 | 27 | 0.030 |
Why?
|
| Mutation | 2 | 2009 | 1169 | 0.030 |
Why?
|
| HLA Antigens | 2 | 1984 | 27 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1993 | 69 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1993 | 143 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 1992 | 4 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 97 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 1998 | 165 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1054 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1266 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1992 | 5 | 0.020 |
Why?
|
| RNA, Bacterial | 2 | 1983 | 38 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 727 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 60 | 0.020 |
Why?
|
| Nucleic Acid Denaturation | 2 | 1983 | 9 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1991 | 82 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 154 | 0.020 |
Why?
|
| Magnesium | 2 | 1983 | 93 | 0.020 |
Why?
|
| Retroviridae | 2 | 1998 | 25 | 0.020 |
Why?
|
| Reticulocytes | 1 | 1990 | 9 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cell-Free System | 2 | 2008 | 15 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 67 | 0.020 |
Why?
|
| Rabbits | 1 | 1990 | 292 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 32 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 33 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2009 | 29 | 0.020 |
Why?
|
| DNA Probes | 1 | 1989 | 33 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1989 | 77 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1990 | 420 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1988 | 6 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1988 | 20 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1988 | 68 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 139 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2009 | 90 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 20 | 0.020 |
Why?
|
| Hela Cells | 1 | 2009 | 370 | 0.020 |
Why?
|
| Chickens | 1 | 1989 | 148 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1988 | 124 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 1987 | 22 | 0.020 |
Why?
|
| Poly A | 1 | 1987 | 33 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1987 | 11 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 98 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2008 | 114 | 0.020 |
Why?
|
| DNA Damage | 1 | 2009 | 358 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2005 | 2 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2007 | 177 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1985 | 30 | 0.010 |
Why?
|
| Polynucleotides | 1 | 1983 | 3 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 7982 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1983 | 53 | 0.010 |
Why?
|
| Interferons | 1 | 1982 | 37 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 1983 | 74 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 1617 | 0.010 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2001 | 29 | 0.010 |
Why?
|
| Response Elements | 1 | 2001 | 55 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 11819 | 0.010 |
Why?
|
| Amino Acids | 1 | 1981 | 150 | 0.010 |
Why?
|
| Polyribonucleotides | 1 | 1979 | 2 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 1979 | 23 | 0.010 |
Why?
|
| Pronase | 1 | 1979 | 4 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1979 | 28 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1979 | 217 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 13458 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1979 | 130 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1998 | 28 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 53 | 0.010 |
Why?
|
| Cell Lineage | 1 | 1998 | 104 | 0.010 |
Why?
|
| Transcription Factor DP1 | 1 | 1997 | 2 | 0.010 |
Why?
|
| E2F5 Transcription Factor | 1 | 1997 | 2 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 1997 | 2 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1997 | 2 | 0.010 |
Why?
|
| Blood Physiological Phenomena | 1 | 1997 | 6 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 1997 | 7 | 0.010 |
Why?
|
| E2F3 Transcription Factor | 1 | 1997 | 12 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 1997 | 10 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 1997 | 22 | 0.010 |
Why?
|
| Tyrosine | 1 | 1997 | 119 | 0.010 |
Why?
|
| Biological Transport | 1 | 1997 | 201 | 0.010 |
Why?
|
| Time Factors | 1 | 1981 | 1848 | 0.010 |
Why?
|
| ets-Domain Protein Elk-4 | 1 | 1993 | 2 | 0.010 |
Why?
|
| Quail | 1 | 1993 | 4 | 0.010 |
Why?
|
| Immune Sera | 1 | 1991 | 56 | 0.010 |
Why?
|
| Antibodies | 1 | 1991 | 140 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 189 | 0.010 |
Why?
|
| Epitopes | 1 | 1991 | 155 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1991 | 199 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 13 | 0.000 |
Why?
|
| Coliphages | 1 | 1983 | 9 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1982 | 17 | 0.000 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1982 | 18 | 0.000 |
Why?
|
| Cricetulus | 1 | 1982 | 82 | 0.000 |
Why?
|
| Cricetinae | 1 | 1982 | 241 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1983 | 323 | 0.000 |
Why?
|
| Templates, Genetic | 1 | 1979 | 24 | 0.000 |
Why?
|
| Lung | 1 | 1982 | 484 | 0.000 |
Why?
|